| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.22 | 0.0005 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.099 | 0.001 |